Abundance of multiple high-risk human papillomavirus (HPV) infections found in cervical cells analyzed by use of an ultrasensitive HPV genotyping assay

Journal of Clinical Microbiology

Volumn 48, Issue 1, 2010, Pages 143-149

  Schmitt, Markus ^a   Dondog, Bolormaa ^a,b   Waterboer, Tim ^a   Pawlita, Michael ^a   Tommasino, Massimo ^b   Gheit, Tarik ^b  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GLOBIN; PROTEIN E7;

ARTICLE; CONTROLLED STUDY; FEMALE; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MIXED INFECTION; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RISK FACTOR; SENSITIVITY AND SPECIFICITY; UTERINE CERVICITIS; VERRUCA VULGARIS; VIRUS DETECTION; VIRUS GENOME;

CERVIX UTERI; DNA PRIMERS; DNA, VIRAL; EPITHELIAL CELLS; FEMALE; GENOTYPE; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; VIROLOGY;

HUMAN PAPILLOMAVIRUS;

EID: 73949085722     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.00991-09     Document Type: Article

References (26)

1. Antonsson, A., O. Forslund, H. Ekberg, G. Sterner, and B. G. Hansson. 2000. The ubiquity and impressive genomic diversity of human skin papillomaviruses suggest a commensalic nature of these viruses. J. Virol. 74:11636-11641.
2. Bauer, H. M., Y. Ting, C. E. Greer, J. C. Chambers, C. J. Tashiro, J. Chimera, A. Reingold, and M. M. Manos. 1991. Genital human papillomavirus infection in female university students as determined by a PCR-based method. JAMA 265:472-477.
3. Bosch, F. X., and N. Munoz. 2002. The viral etiology of cervical cancer. Virus Res. 89:183-190.
4. Cazzaniga, M., T. Gheit, C. Casadio, N. Khan, D. Macis, F. Valenti, M. J. Miller, B. S. Sylla, S. Akiba, B. Bonanni, A. Decensi, U. Veronesi, and M. Tommasino. 2009. Analysis of the presence of cutaneous and mucosal papillomavirus types in ductal lavage fluid, milk and colostrum to evaluate its role in breast carcinogenesis. Breast Cancer Res. Treat. 114:599-605.
5. Cuschieri, K. S., H. A. Cubie, M. W. Whitley, A. L. Seagar, M. J. Arends, C. Moore, G. Gilkisson, and E. McGoogan. 2004. Multiple high risk HPV infections are common in cervical neoplasia and young women in a cervical screening population. J. Clin. Pathol. 57:68-72.
6. de Roda Husman, A. M., J. M. Walboomers, A. J. van den Brule, C. J. Meijer, and P. J. Snijders. 1995. The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J. Gen. Virol. 76(Pt 4):1057-1062.
7. de Villiers, E. M., C. Fauquet, T. R. Broker, H. U. Bernard, and H. zur Hausen. 2004. Classification of papillomaviruses. Virology 324:17-27.
8. Dondog, B., G. M. Clifford, S. Vaccarella, T. Waterboer, D. Unurjargal, D. Avirmed, S. Enkhtuya, F. Kommoss, N. Wentzensen, P. J. Snijders, C. J. Meijer, S. Franceschi, and M. Pawlita. 2008. Human papillomavirus infection in Ulaanbaatar, Mongolia: a population-based study. Cancer Epidemiol. Biomarkers Prev. 17:1731-1738.
9. Gheit, T., S. Landi, F. Gemignani, P. J. Snijders, S. Vaccarella, S. Franceschi, F. Canzian, and M. Tommasino. 2006. Development of a sensitive and specific assay combining multiplex PCR and DNA microarray primer extension to detect high-risk mucosal human papillomavirus types. J. Clin. Microbiol. 44:2025-2031.
10. Han, J., D. C. Swan, S. J. Smith, S. H. Lum, S. E. Sefers, E. R. Unger, and Y. W. Tang. 2006. Simultaneous amplification and identification of 25 human papillomavirus types with Templex technology. J. Clin. Microbiol. 44:4157-4162.
11. Herrero, R., A. Hildesheim, C. Bratti, M. E. Sherman, M. Hutchinson, J. Morales, I. Balmaceda, M. D. Greenberg, M. Alfaro, R. D. Burk, S. Wacholder, M. Plummer, and M. Schiffman. 2000. Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. J. Natl. Cancer Inst. 92:464-474.
12. Jenkins, D. 2008. A review of cross-protection against oncogenic HPV by an HPV-16/18 AS04-adjuvanted cervical cancer vaccine: importance of virological and clinical endpoints and implications for mass vaccination in cervical cancer prevention. Gynecol Oncol. 110:S18-S25.
13. Kalendar, R., D. Lee, and A. H. Schulman. 2009. FastPCR software for PCR primer and probe design and repeat search. Genes Genomes Genomics 3(1). www.biocenter.helsinki.fi/bi/Programs/fastpcr.htm.
14. Kleter, B., L. J. van Doorn, L. Schrauwen, A. Molijn, S. Sastrowijoto, J. ter Schegget, J. Lindeman, B. ter Harmsel, M. Burger, and W. Quint. 1999. Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus. J. Clin. Microbiol. 37:2508-2517.
15. Kovacs, K., A. D. Varnai, M. Bollmann, A. Bankfalvi, M. Szendy, N. Speich, C. Schmitt, L. Pajor, and R. Bollmann. 2008. Prevalence and genotype distribution of multiple human papillomavirus infection in the uterine cervix: a 7.5-year longitudinal study in a routine cytology-based screening population in West Germany. J. Med. Virol. 80:1814-1823.
16. Levi, J. E., B. Kleter, W. G. Quint, M. C. Fink, C. L. Canto, R. Matsubara, I. Linhares, A. Segurado, B. Vanderborght, J. E. Neto, and L. J. Van Doorn. 2002. High prevalence of human papillomavirus (HPV) infections and high frequency of multiple HPV genotypes in human immunodeficiency virus-infected women in Brazil. J. Clin. Microbiol. 40:3341-3345.
17. Mendez, F., N. Munoz, H. Posso, M. Molano, V. Moreno, A. J. van den Brule, M. Ronderos, C. Meijer, and A. Munoz. 2005. Cervical coinfection with human papillomavirus (HPV) types and possible implications for the prevention of cervical cancer by HPV vaccines. J. Infect. Dis. 192:1158-1165.
18. Munoz, N., F. X. Bosch, S. de Sanjose, R. Herrero, X. Castellsague, K. V. Shah, P. J. Snijders, and C. J. Meijer. 2003. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N. Engl. J. Med. 348:518-527.
19. Qu, W., G. Jiang, Y. Cruz, C. J. Chang, G. Y. Ho, R. S. Klein, and R. D. Burk. 1997. PCR detection of human papillomavirus: comparison between MY09/MY11 and GP5+/GP6+ primer systems. J. Clin. Microbiol. 35:1304-1310.
20. Rousseau, M. C., J. S. Pereira, J. C. Prado, L. L. Villa, T. E. Rohan, and E. L. Franco. 2001. Cervical coinfection with human papillomavirus (HPV) types as a predictor of acquisition and persistence of HPV infection. J. Infect. Dis. 184:1508-1517.
21. Schiffman, M. H., H. M. Bauer, R. N. Hoover, A. G. Glass, D. M. Cadell, B. B. Rush, D. R. Scott, M. E. Sherman, R. J. Kurman, S. Wacholder, et al. 1993. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J. Natl. Cancer Inst. 85:958-964.
22. Schmitt, M., I. G. Bravo, P. J. Snijders, L. Gissmann, M. Pawlita, and T. Waterboer. 2006. Bead-based multiplex genotyping of human papillomaviruses. J. Clin. Microbiol. 44:504-512.
23. Schmitt, M., B. Dondog, T. Waterboer, and M. Pawlita. 2008. Homogeneous amplification of genital human alpha papillomaviruses by PCR using novel broad-spectrum GP5+ and GP6+ primers. J. Clin. Microbiol. 46:1050-1059.
24. van den Brule, A. J., R. Pol, N. Fransen-Daalmeijer, L. M. Schouls, C. J. Meijer, and P. J. Snijders. 2002. GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. J. Clin. Microbiol. 40:779-787.
25. van Doorn, L. J., W. Quint, B. Kleter, A. Molijn, B. Colau, M. T. Martin, I. Kravang, N. Torrez-Martinez, C. L. Peyton, and C. M. Wheeler. 2002. Genotyping of human papillomavirus in liquid cytology cervical specimens by the PGMY line blot assay and the SPF(10) line probe assay. J. Clin. Microbiol. 40:979-983.
26. Walboomers, J. M., M. V. Jacobs, M. M. Manos, F. X. Bosch, J. A. Kummer, K. V. Shah, P. J. Snijders, J. Peto, C. J. Meijer, and N. Munoz. 1999. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 189:12-19.